This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
A new serum containing 2-mercaptonicotinoyl glycine as its main ingredient was at least as good as cysteamine 5% cream in treating facial melasma in a randomized study.
Medscape Medical News